ARCHIVES

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

This article is from The Cancer Letter archive.

Vol. 10 No. 46 | November 30, 1984

Download PDF Visit The Full Archive

Related Articles

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013